||**Trustees' Annual Report**|**Trustees' Annual Report**|**Trustees' Annual Report**|**Trustees' Annual Report**|**for the period**|**for the period**|**for the period**|**for the period**|**for the period**||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||Period start date|||Period end date||||||||
|||1|August<br>2022|**T**|31|July|||2023||||
||**From**|||**o**|||||||||
|Section A|||Reference and administration details||||||||||
|**Charity name**|||||BONDED THRU CANCER||||||||
||||||||||||||
|**Other names charity is known by**||||||N/A|||||||
||||||||||||||
|**Registered charity number (if**<br>**any)**|||1183619||||||||||
||||||||||||||
|**Charity's principal address**|||The Trampery, Import Building, 2 Clove Crescent||||||||||
||||London||||||||||
||||||||||||||
||||**Postcode**|||||**E14 2BE**|||||
|**Names of**|**the charity trustees who manage the charity**||||||||||||



||**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or body) entitled to**<br>**appoint trustee (if any)**|
|---|---|---|---|---|
|1|Natasha<br>Veerasawmy|Chair|||
|2|Paulina Balogun|Treasurer|||
|3|Pamela<br>Hammond|Secretary|||
|4|||||
|5|||||
|6|||||
|7|||||
|8|||||
|9|||||
|10|||||
|11|||||
|12|||||
|13|||||
|14|||||





**Names of the trustees for the charity, if any, (for example, any custodian trustees)** 

**Name Dates acted if not for whole year** 

## **Names and addresses of advisers (Optional information)** 

**Type of adviser Name Address** 

## **Name of chief executive or names of senior staff members (Optional information)** 

## **Section B Structure, governance and management** 

## **Description of the charity’s trusts** 

Type of governing document Constitution (eg. trust deed, constitution) 

How the charity is constituted 

Trust 

- (eg. trust, association, company) 

Trustee selection methods Trustees are elected by Committee Members. 

- (eg. appointed by, elected by) 

## **Additional governance issues (Optional information)** 

You **may choose** to include additional information, where relevant, about: 

- policies and procedures adopted for the induction and training of trustees; 

- the charity’s organisational structure and any wider network with which the charity works; 

- relationship with any related parties; 

- trustees’ consideration of major risks and the system and procedures to manage them. 




**Section C** 

**Objectives and activities** 

|**Summary of the objects of the**<br>**charity set out in its governing**<br>**document**<br>**Summary of the main activities**<br>**undertaken for the public**<br>**benefit in relation to these**<br>**objects (include within this**<br>**section the statutory**<br>**declaration that trustees have**<br>**had regard to the guidance**<br>**issued by the Charity**<br>**Commission on public benefit)**|To promote the wellbeing of newly diagnosed cancer patients.<br>To befriend newly diagnosed patients and support them through their<br>medical treatment and their aftermath.<br>To educate the public and the medical profession about the emotional<br>needs of those who have been newly diagnosed with cancer.<br>To offer wellbeing education around diet and exercise.|
|---|---|
||Buddy system –During this time, trustees were allocated a recently<br>diagnosed cancer patient to offer friendship and support to. Trustees,<br>were also tasked with accompanying cancer patients to and from their<br>hospital appointments.<br>Trustees provided complimentary meals once a week to recently<br>diagnosed cancer patients as a gesture of support for their overall well-<br>being, both physically and mentally.<br>Bonded Thru Cancer have delivered free support workshops (around<br>diet and exercise) toTrustees, members of the medical profession,<br>members of the public (who are associated with cancer patients)<br>and newly diagnosed cancer patients.<br>Public Benefit<br>The key aim of this initiative is to enhance the physical and mental<br>wellbeing of newly diagnosed cancer patients, ultimately leading to an<br>improved coping mechanism. The primary goal is to alleviate<br>symptoms of poor mental health and physical wellbeing, while also<br>supporting the initial medical treatment process.<br>The community set to benefit from this public service includes newly<br>diagnosed cancer patients, medical professionals involved in their care,<br>volunteers supporting the initiative, and members of the public who<br>have direct contact with individuals facing a recent cancer diagnosis.<br>Evaluation<br>Prior to the workshop and upon its completion, an initial survey is<br>administered to newly diagnosed cancer patients and their family<br>members to assess their mental health status. Similarly, all participants<br>|
||~~of the community dinner program receive surveys to evaluate their~~<br>feelings of contentment, confidence, and overall outlook before and<br>after the meal. These surveys are designed to measure the impact and|
||<br>effectiveness of the workshops and the community dinner program on<br>the participants' well-being.|



**Additional details of objectives and activities (Optional information)** 



You **may choose** to include further statements, where relevant, about: 

- policy on grantmaking; 

- policy programme related investment; 

- contribution made by volunteers. 

Section D 


Achievements and performance 



## Section D Achievements and performance 

**Summary of the main achievements of the charity during the year** 

BTC was able to fundraise £ 3400 this went towards BTC main activities. BTC was able to utilise Trustees to carry out its objectives. BTC was able to support 12 newly diagnosed cancer patients via our food delivery service. BTC was able to support the wellbeing and mental health of 18 family members via our support workshops and community meals which were delivered virtually. 



**Section E                    Financial review** 

**Brief statement of the** All reserves are carried forward to the next financial year and allocated to **charity’s policy on reserves** the Trusts objectives and constituted activities. 

**Details of any funds materially** n/a **in deficit** 

## **Further financial review details (Optional information)** 

You **may choose** to include additional information, where relevant about: 

- the charity’s principal sources of funds (including any fundraising); 

- how expenditure has supported the key objectives of the charity; 

- investment policy and objectives including any ethical investment policy adopted. 


## **Section F                     Other optional information** 

## **Section G                    Declaration** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

**Signature(s)** 

**Full name(s)** Paulina Balogun 



**Position (eg Secretary,** Treasurer **Chair, etc)** 

**Date** 15 .0 7 .202 4 



||**Bonded Thru Cancer**|**Bonded Thru Cancer**|**Bonded Thru Cancer**|**Bonded Thru Cancer**|**Bonded Thru Cancer**|**No(if any)**<br>~~1183619~~|**No(if any)**<br>~~1183619~~||
|---|---|---|---|---|---|---|---|---|
||||||||||
||**Receipts andpayments accounts**||||||||
||**For the period**<br>**from**||01.08.2022||**To**||31.07.2023||
||||||||||
||||||||||
|**Section A Receipts and payments**|||||||||
||**Unrestricted**<br>**funds**||**Restricted funds**||**Endowment**<br>**funds**||**Total funds**||
||**to the nearest      £**||**to the nearest £**||**to the nearest £**||**to the nearest £**||
|**A1 Receipts**|||||||||
||**5413**||**-**||**-**||**5413**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
|**_Sub total_**_(Gross income for AR)_|**5413**||**-**||**-**||**5413**||
||||||||||
|**A2 Asset and investment sales,**<br>**(see table).**|||||||||
||**- 0**||**- 0**||**- 0**||**-**||
||**- 0**||**- 0**||**- 0**||**-**||
|**_Sub total _**|<br>**- 0**||**- 0**||**- 0**||**-**||
||||||||||
|**_Total receipts_**|**5413**||**- 0**||**- 0**||**5413**||
||||||||||
|**A3 Payments**|||||||||
||**5413**||**-**||**-**||**5413**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
|**_Sub total_**|**5413**||**-**||**-**||**5413**||
||||||||||
|**A4 Asset and investment**<br>**purchases,(see table)**|||||||||
||**- 0**||**- 0**||**- 0**||**-**||
||**- 0**||**- 0**||**- 0**||**-**||
|**_Sub total_**|**-0**||**-0**||**-0**||**-**||
||||||||||
|**_Totalpayments_**|**5413**||**- 0**||**- 0**||**5413**||
||||||||||
|**_Net of receipts/(payments)_**|**0**||**-**||**-**||**0**||
|**A5 Transfers between funds**|**- 0**||**-**||**-**||**-**||
|**A6 Cash funds lastyear end**|**- 0**||**-**||**-**||**-**||
|**_Cash funds thisyear end_**|**0**||**-**||**-**||**0**||
||||||||||
||||||||||
|**Section B Statement of assets and liabilities at the end of the period**|||||||||
|**Categories**|**Details**||||**Unrestricted**<br>**funds**||**Restricted funds**||
||||||**to nearest £**||**to nearest £**||
|**B1 Cash funds**|||||**-**||**-**||
||||||**-**||**-**||



CCXX R1 accounts (SS) 

15/07/2024 

1 



||||||**-**||**-**||
|---|---|---|---|---|---|---|---|---|
||**_Total cash funds_**||||**-**||**-**||
||(agree balances with receipts and payments<br>account(s))||||Agreement Error||||
||||||**Unrestricted**<br>**funds**||**Restricted funds**||
||**Details**||||**to nearest £**||**to nearest £**||
|**B2 Other monetary assets**|||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||||||
||**Details**||||**Fund to which asset**<br>**belongs**||**Cost (optional)**||
|**B3 Investment assets**|||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||||
||**Details**||||**Fund to which asset**<br>**belongs**||**Cost (optional)**||
|**B4 Assets retained for the**<br>**charity’s own use**|||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||||
||**Details**||||**Fund to which**<br>**liability relates**||**Amount due**<br>**(optional)**||
|**B5 Liabilities**|||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||||
|Signed by one or two trustees on behalf<br>of all the trustees|||||Print Name||||
||P A Balogun||||P A Balogun||||
||||||||||



CCXX R2 accounts (SS) 

15/07/2024 

2 



## **CC16a** 


**Last year to the nearest £ - - - - - - - - - - 0 - 0 - 0 - - - - - - - - - - - 0 - 0 - - - - Endowment funds to nearest £ - -** 

CCXX R3 accounts (SS) 

15/07/2024 

3 



**-** OK **Endowment funds to nearest £ - - - - - - Current value (optional) - - - - - Current value (optional) - - - - - - - - - When due (optional)** 


## Date of approval 

15.07.2024 

CCXX R4 accounts (SS) 

15/07/2024 

4